BiotechTube
Home/Prescient Therapeutics/Melanie Leydin
ML

Melanie Leydin

Company Secretary

Prescient Therapeutics

Therapeutic Areas

Oncology

Prescient Therapeutics Pipeline

DrugIndicationPhase
PTX-100Relapsed/refractory Cutaneous T‑Cell LymphomaPhase 2a
CellPrymeCAR‑T enhancement platformPreclinical
OmniCARUniversal CAR‑T platformPreclinical

Leadership Team at Prescient Therapeutics

DJ
Dr James Campbell
Non‑Executive Chairman
DA
Dr Allen Ebens
Non‑Executive Director
MF
Melanie Farris
Non‑Executive Director
DE
Dr Ellen Feigal
Non‑Executive Director
DG
Dr Gavin Shepherd
Non‑Executive Director
View full Prescient Therapeutics profile